The role of the caregiver, the person who organizes and defines the care needed by a non-self-sufficient individual, can be ...

Tuesday, July 1st is an open day at Federico II for the Department of Social Sciences, where specific academic paths, career ...

Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...

Already a household name in diabetes and weight management, Ozempic (semaglutide) may soon find another surprising role — as ...

A recent study suggests that liraglutide, a drug similar to Ozempic, may reduce migraine frequency in obese individuals with ...

People with unresponsive chronic migraine and obesity experienced substantial relief after they started taking a GLP-1 drug, researchers in Italy have found.

A GLP-1 drug led to fewer days with headaches, a small pilot study of migraine sufferers shows. It may work by lowering pressure inside the head.

For adults with obesity and migraine, liraglutide reduces migraine burden, with reductions in mean monthly headache days.

Liraglutide, a medication commonly used to treat diabetes, has shown promising results in reducing chronic migraine in ...

The obesity drug liraglutide cut migraine days in half in a small trial, though more research is needed to exclude the placebo effect, researchers said.

Blockbuster weight-loss shots like Ozempic, Wegovy and Victoza may have an unexpected side effect impacting as many as ...